Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.50
Ask:
3.90
Spread: 0.40 (11.429%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Option Cancellation and Registered Office Change

23 Nov 2020 07:00

RNS Number : 0906G
Primorus Investments PLC
23 November 2020
Β 

Β 

Primorus Investments PLC

Β 

("Primorus" or the "Company")

Β 

Cancellation of Options and Change of Registered Office

Β 

Primorus Investments PLC (AIM: PRIM; AQSE: PRIM) is pleased to announce the following corporate updates as part of its previously announced strategic review:

Cancellation of Share Options:

The Company has entered into a deed of termination and settlement with individual optionholders (the "Optionholders") who held options to subscribe for ordinary shares of 0.2 pence each in the capital of the Company (the "Share Options"), pursuant to which all Share Options in issue, being an aggregate of 17,800,000 Share Options, have been cancelled forthwith. Full details of the Share Options, including their exercise prices and periods, are set out in the Company's annual report for the year ended 31 December 2019 (see note 13 in the notes to the financial statements contained therein), a copy of which can be downloaded from the Company's website at the following link:

https://www.primorusinvestments.com/wp-content/uploads/2020/04/Primorus-ARA-2019-FINAL.pdf.

In consideration for the Optionholders relinquishing all their rights to the Share Options and the Company cancelling the same, the Company has paid an aggregate sum of Β£140,000 to the Optionholders. The Company and the Optionholders have also agreed to irrevocably release and discharge each other in respect of any actions, claims or demands under or in connection with the Options.

All but one of the Optionholders have been directors of the Company within the last 12 months ("Former Directors"). Details of the cancellation of the Former Directors' Share Options are set out below:

Name

Number of Share Options Surrendered

Cash Payment (Β£)

Alastair Clayton

8,100,000

65,625.00

Jeremy Taylor-Firth

4,350,000

32,812.50

Donald Strang

4,850,000

37,187.50

Β 

The cancellation of the Former Directors' Share Options described above is deemed to be a related party transaction for the purposes of Rule 13 of the AIM Rules. The board of the Company, being deemed to be independent of the related party transaction, considers, having consulted with the Company's Nominated Adviser, that the terms of the transaction are fair and reasonable insofar as shareholders are concerned.

The Company has 139,830,968 ordinary shares of 0.2 pence each in issue, on a fully diluted basis. Shareholders should use this number as the denominator to calculate their percentage holding in the Company.

Change of Registered Office:

The Company also announces, effective immediately, that its registered office has changed to 48 Chancery Lane, London WC2A 1JF.

Β 

Rupert Labrum, Executive Chairman, said:Β "As part of the recently appointed Board's strategic review of the Company's business, we were keen to address the issue of the Share Options. On a fully diluted basis, the Share Options amounted to 11.3 per cent. of the Company's share capital, which we felt was high. Whilst the Share Options could be exercised at prices of 6p and 8p each, meaning there would need to be an increase to our current share price to make it attractive for the option holders to exercise, any benefit of leaving them in place was significantly diminished with exercise periods running until 2023 and 2025.

"Coupled with the significant overhang which the Share Options represent to the Company's share capital and because the Optionholders are no longer directly involved with the Company, other than as shareholders, the Board felt it was in the best interests of our shareholders and the Company as a whole to address this matter sooner rather than later.

"With the recent Greatland Gold share divestment and the cancellation of the Share Options, the Board believes the immediate strengthening of our balance sheet will put the Company in a strong position as it looks towards future investment opportunities."

Β 

The Directors of Primorus accept responsibility for the content of this announcement.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Β 

For further information, please contact:

Β 

Primorus Investments plc:

+44 (0) 20 7213 0880

Β 

Rupert Labrum

Nominated Adviser:

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

Broker:

+44 (0) 20 3657 0050

Turner Pope Investments (TPI) Limited

Andy Thacker / Zoe Alexander

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CROPPGBGGUPUGMP
Date   Source Headline
19th Jun 20264:15 pmRNSNotice of AGM & Proposed Rule 9 Waiver
12th Jun 20263:36 pmRNSHolding(s) in Company
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.